{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:40:23Z","timestamp":1791859223504,"version":"4.3.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1124\/mol.107.040824","type":"journal-article","created":{"date-parts":[[2007,12,20]],"date-time":"2007-12-20T01:44:37Z","timestamp":1198115077000},"page":"778-788","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Interferon \u03b2 Augments Tuberous Sclerosis Complex 2 (TSC2)-Dependent Inhibition of TSC2-Null ELT3 and Human Lymphangioleiomyomatosis-Derived Cell Proliferation"],"prefix":"10.1016","volume":"73","author":[{"given":"Elena A.","family":"Goncharova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry A.","family":"Goncharov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Chisolm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew S.","family":"Spaits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poay N.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Cesarone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Khavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Tliba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yassine","family":"Amrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Reynold A.","family":"Panettieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera P.","family":"Krymskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.107.040824_REF1","doi-asserted-by":"crossref","first-page":"L1063","DOI":"10.1152\/ajplung.00363.2002","article-title":"IFN-gamma inhibits human airway smooth muscle cell proliferation by modulating the E2F-1\/Rb pathway","volume":"284","author":"Amrani","year":"2003","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1124\/mol.107.040824_REF2","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1086\/342718","article-title":"Association between a high-expressing interferon-gamma allele and a lower frequency of kidney angiomyolipomas in TSC2 patients","volume":"71","author":"Dabora","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1124\/mol.107.040824_REF3","doi-asserted-by":"crossref","first-page":"20053","DOI":"10.1074\/jbc.R700006200","article-title":"Type I interferon receptors: biochemistry and biological functions","volume":"282","author":"de Weerd","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.040824_REF4","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni1102-991","article-title":"Cancer immunoediting: from immunosurveillance to tumor escape","volume":"3","author":"Dunn","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1124\/mol.107.040824_REF5","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1165\/rcmb.2005-0152RC","article-title":"Interferon-{gamma}-Jak-Stat signaling in pulmonary lymphangioleiomyomatosis and renal angiomyolipoma: a potential therapeutic target","volume":"33","author":"El-Hashemite","year":"2005","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1124\/mol.107.040824_REF6","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1158\/0008-5472.CAN-03-3609","article-title":"Perturbed IFN-gamma-Jak-signal transducers and activators of transcription signaling in tuberous sclerosis mouse models: synergistic effects of rapamycin-IFN-gamma treatment","volume":"64","author":"El-Hashemite","year":"2004","journal-title":"Cancer Res"},{"key":"10.1124\/mol.107.040824_REF7","doi-asserted-by":"crossref","first-page":"L354","DOI":"10.1152\/ajplung.00010.2002","article-title":"Phosphatidylinositol 3-kinase is required for proliferation and migration of human pulmonary vascular smooth muscle cells","volume":"283","author":"Goncharova","year":"2002","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1124\/mol.107.040824_REF8","doi-asserted-by":"crossref","first-page":"30958","DOI":"10.1074\/jbc.M202678200","article-title":"Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation: a role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM)","volume":"277","author":"Goncharova","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.040824_REF9","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1083\/jcb.200405130","article-title":"TSC2 modulates actin cytoskeleton and focal adhesion through TSC1-binding domain and the Rac1 GTPase","volume":"167","author":"Goncharova","year":"2004","journal-title":"J Cell Biol"},{"key":"10.1124\/mol.107.040824_REF10","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1165\/rcmb.2005-0300OC","article-title":"Abnormal smooth muscle cell growth in lymphangioleiomyomatosis (LAM): role for tumor suppressor TSC2","volume":"34","author":"Goncharova","year":"2006","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1124\/mol.107.040824_REF11","unstructured":"Goncharova EA and Krymskaya VP (2008) Pulmonary lymphangioleiomyomatosis (LAM): progress and current challenges. J Cell Biochem, in press."},{"key":"10.1124\/mol.107.040824_REF12","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1038\/nprot.2006.433","article-title":"Assays for in vitro monitoring proliferation of human airway smooth muscle (ASM) and human pulmonary arterial vascular smooth muscle (VSM) cells","volume":"1","author":"Goncharova","year":"2006","journal-title":"Nat Protoc"},{"key":"10.1124\/mol.107.040824_REF13","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/sj.clpt.6100317","article-title":"Rapamycin: something old, something new, sometimes borrowed and now renewed","volume":"82","author":"Hartford","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/mol.107.040824_REF14","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1349-7006.2003.tb01410.x","article-title":"Renal carcinogenesis: genotype, phenotype and dramatype","volume":"94","author":"Hino","year":"2003","journal-title":"Cancer Sci"},{"key":"10.1124\/mol.107.040824_REF15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ng1494","article-title":"Dysregulation of the TSC-mTOR pathway in human disease","volume":"37","author":"Inoki","year":"2005","journal-title":"Nat Genet"},{"key":"10.1124\/mol.107.040824_REF16","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1183\/09031936.06.00113303","article-title":"Lymphangioleiomyomatosis","volume":"27","author":"Johnson","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1124\/mol.107.040824_REF17","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1165\/rcmb.2006-0372TR","article-title":"Molecular pathogenesis of lymphangioleiomyomatosis: lessons learned from orphans","volume":"36","author":"Juvet","year":"2007","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1124\/mol.107.040824_REF18","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s000180050248","article-title":"The structure of human interferon-beta: implications for activity","volume":"54","author":"Karpusas","year":"1998","journal-title":"Cell Mol Life Sci"},{"key":"10.1124\/mol.107.040824_REF19","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/toxsci\/kfi310","article-title":"Tsc2 expression increases the susceptibility of renal tumor cells to apoptosis","volume":"88","author":"Kolb","year":"2005","journal-title":"Toxicol Sci"},{"key":"10.1124\/mol.107.040824_REF20","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0898-6568(03)00040-8","article-title":"Tumour suppressors hamartin and tuberin: intracellular signalling","volume":"15","author":"Krymskaya","year":"2003","journal-title":"Cell Signal"},{"key":"10.1124\/mol.107.040824_REF21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1513\/pats.200705-061VS","article-title":"Smooth muscle-like cells in lymphangioleiomyomatosis","volume":"5","author":"Krymskaya","year":"2008","journal-title":"Proc Am Thorac Soc"},{"key":"10.1124\/mol.107.040824_REF22","doi-asserted-by":"crossref","first-page":"L1009","DOI":"10.1152\/ajplung.2001.280.5.L1009","article-title":"Activation of class IA PI3K stimulates DNA synthesis in human airway smooth muscle cells","volume":"280","author":"Krymskaya","year":"2001","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1124\/mol.107.040824_REF23","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1165\/rcmb.F267","article-title":"Lymphangioleiomyomatosis: a complex tale of serum response factor-mediated tissue inhibitor of metalloproteinase-3 regulation","volume":"28","author":"Krymskaya","year":"2003","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1124\/mol.107.040824_REF24","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/hmg\/11.5.525","article-title":"A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells","volume":"11","author":"Kwiatkowski","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1124\/mol.107.040824_REF25","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/gcc.20357","article-title":"Combination of a rapamycin analog (CCI-779) and interferon-gamma is more effective than single agents in treating a mouse model of tuberous sclerosis complex","volume":"45","author":"Lee","year":"2006","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1124\/mol.107.040824_REF26","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1093\/hmg\/9.12.1721","article-title":"The TSC1 gene product, hamartin, negatively regulates cell proliferation","volume":"9","author":"Miloloza","year":"2000","journal-title":"Human Molecular Genetics"},{"key":"10.1124\/mol.107.040824_REF27","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0163-7258(03)00016-0","article-title":"The p38 mitogen-activated protein kinase pathway and its role in interferon signaling","volume":"98","author":"Platanias","year":"2003","journal-title":"Pharmacol Ther"},{"key":"10.1124\/mol.107.040824_REF28","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri1604","article-title":"Mechanisms of type-I- and type-II-interferon-mediated signalling","volume":"5","author":"Platanias","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1124\/mol.107.040824_REF29","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/nrc928","article-title":"New aspects of natural-killer-cell surveillance and therapy of cancer","volume":"2","author":"Smyth","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1124\/mol.107.040824_REF30","doi-asserted-by":"crossref","first-page":"29301","DOI":"10.1074\/jbc.272.46.29301","article-title":"Role of the tuberous sclerosis gene-2 product in cell cycle control","volume":"272","author":"Soucek","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.040824_REF31","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev.biochem.67.1.227","article-title":"How cells respond to interferons","volume":"67","author":"Stark","year":"1998","journal-title":"Annu Rev Biochem"},{"key":"10.1124\/mol.107.040824_REF32","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1349-7006.2003.tb01455.x","article-title":"New aspects of IFN-alpha\/beta signalling in immunity, oncogenesis and bone metabolism","volume":"94","author":"Takaoka","year":"2003","journal-title":"Cancer Sci"},{"key":"10.1124\/mol.107.040824_REF33","doi-asserted-by":"crossref","first-page":"7989","DOI":"10.1128\/JVI.74.17.7989-7996.2000","article-title":"Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein","volume":"74","author":"Talon","year":"2000","journal-title":"J Virol"},{"key":"10.1124\/mol.107.040824_REF34","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0092-8674(01)00332-4","article-title":"The Drosophila tuberous sclerosis complex gene homologs restrict cell growth and cell proliferation","volume":"105","author":"Tapon","year":"2001","journal-title":"Cell"},{"key":"10.1124\/mol.107.040824_REF35","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1177\/107327480601300405","article-title":"Lymphangioleiomyomatosis","volume":"13","author":"Taveira-DaSilva","year":"2006","journal-title":"Cancer Control"},{"key":"10.1124\/mol.107.040824_REF36","doi-asserted-by":"crossref","first-page":"24152","DOI":"10.1074\/jbc.M312219200","article-title":"Interferon \u03b1-induced apoptosis in tumor cells is mediated through the phosphoinositide 3-kinase\/mammalian target of rapamycin signaling pathway","volume":"279","author":"Thyrell","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.040824_REF37","doi-asserted-by":"crossref","first-page":"50615","DOI":"10.1074\/jbc.M303680200","article-title":"Tumor necrosis factor \u03b1 modulates airway smooth muscle function via the autocrine action of interferon \u03b2","volume":"278","author":"Tliba","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.107.040824_REF38","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1023\/A:1023805715476","article-title":"Jak family of kinases in cancer","volume":"22","author":"Verma","year":"2003","journal-title":"Cancer Metastasis Rev"},{"key":"10.1124\/mol.107.040824_REF39","doi-asserted-by":"crossref","first-page":"8379","DOI":"10.1158\/0008-5472.CAN-05-0920","article-title":"Intrapulmonary IFN-{beta} gene therapy using an adenoviral vector is highly effective in a murine orthotopic model of bronchogenic adenocarcinoma of the lung","volume":"65","author":"Wilderman","year":"2005","journal-title":"Cancer Res"},{"key":"10.1124\/mol.107.040824_REF40","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1158\/0008-5472.CAN-05-2447","article-title":"Mechanism by which mammalian target of rapamycin inhibitors sensitize multiple myeloma cells to dexamethasone-induced apoptosis","volume":"66","author":"Yan","year":"2006","journal-title":"Cancer Res"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24047710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24047710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.107.040824","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:56:07Z","timestamp":1739958967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24047710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0026895X24047710"],"URL":"https:\/\/doi.org\/10.1124\/mol.107.040824","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interferon \u03b2 Augments Tuberous Sclerosis Complex 2 (TSC2)-Dependent Inhibition of TSC2-Null ELT3 and Human Lymphangioleiomyomatosis-Derived Cell Proliferation","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.107.040824","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2008 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}